Project Grant 2335396
Award Date
12/1/23
Completion Date
11/30/24
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
CASTLE SHANN, PA 15234, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) project awarded $275,000 to Aneurisk, Inc. to develop and validate machine learning models for risk classification, growth projection, and wall stress prediction for abdominal aortic aneurysms (AAAs). The goal is to create an artificial intelligence-based clinical decision support tool that can help clinicians better identify high-risk AAA patients...
Qas.ai Inc. was awarded a $255,577 Small Business Technology Transfer (STTR) Phase I Project Grant by the National Science Foundation on July 15, 2021 to develop an AI-enhanced angiographic system to guide endovascular treatment of intracranial aneurysms. The STTR Phase I Project Grant program, administered under the National Science Foundation's Technology, Innovation, and Partnerships Directorate (TIP), provides funding for the exploration of the technical feasibility or scientific merit of...
The National Science Foundation (NSF) awarded a $275,000 Phase I Small Business Technology Transfer (STTR) grant under the Technology, Innovation, and Partnerships (CFDA 47.084) program to Neuraltrak, Inc., a minority-owned, for-profit small business located in Los Altos, California. The award supports the development and validation of an AI-powered method for continuous, real-time, and accurate monitoring of cardiac rhythms after surgery. This technology aims to address the limitations of...
This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II Cooperative Agreement award of $984,381 to Cobio Diagnostics Inc. aims to expand a new diagnostic technology for rapid, direct-from-specimen identification and antimicrobial susceptibility testing of major bloodborne bacterial pathogens, known as the "ESKAPE" pathogens. The project, funded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, will develop and validate...
This $305,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of an innovative breast cancer screening technology by Bired Imaging Inc. in Rochester, NY. The project aims to create an efficient thermal-spatial point-cloud extraction and rapid physics-based AI algorithm to accurately detect breast cancer from infrared images, especially in women with dense...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) project grant for $274,990 aims to develop a prototype endoscope diagnostic cancer sensor using laser-activated plasmonic nanobubbles (PNB). The project integrates PNB sensors into a medical device platform and a standard clinical endoscope to perform minimally invasive, optically-based lung cancer diagnostic procedures. The objective is to develop a...
The National Science Foundation (NSF) awarded a $274,920 SBIR Phase I project grant under its Technology, Innovation, and Partnerships (CFDA 47.084) program to Arclet LLC, a woman-owned small business located in Asheville, North Carolina. The project aims to enhance public health communication by leveraging artificial intelligence (AI) and natural language processing (NLP) technologies to help health communicators create, customize, share, and measure the effectiveness of health messages...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) project grant, awarded to Anvil Diagnostics Inc., aims to develop a rapid diagnostic test for sepsis-causing pathogens in plasma samples using available digital PCR hardware. The $298,646 award, made on January 15, 2025, seeks to create a highly sensitive, fast, and comprehensive pathogen detection panel suitable for neonates requiring less than 1 mL...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $305,000 provides funding to Giant Biosystems Inc., a small business located in Pasadena, CA, to develop a rapid antimicrobial susceptibility testing (AST) platform. The key products and services to be delivered through this award include:
Creation of a point-of-care AST kit that can provide results within 6-9 hours of sample collection, significantly faster than current...
The National Science Foundation (NSF) awarded a $274,750 Small Business Innovation Research (SBIR) Phase I grant to Amplified Sciences Inc. on March 15, 2024 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a surface-enhanced Raman spectroscopy (SERS)-based diagnostic platform to detect and monitor multiple inflammatory biomarkers associated with various cancers. Key objectives include: 1) synthesizing ultrasensitive SERS-active dye...